<!DOCTYPE html>
<html lang="en">
<head>        <meta charset="utf-8">
        <meta name="viewport" content="width=device-width, initial-scale=1.0">    <link
        rel="stylesheet"
        href="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/css/bootstrap.min.css"
        integrity="sha384-Gn5384xqQ1aoWXA+058RXPxPg6fy4IWvTNh0E263XmFcJlSAwiGgFAW/dAiS6JXm"
        crossorigin="anonymous"
    />
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/c3/0.6.12/c3.min.css"/>
    <style>
        h2 {
            margin-top: 35px;
        }

        html, body {
            height: 100%;
        }

        body {
            display: flex;
            flex-flow: column;
        }

        .footer {
            margin-top: auto;
            padding-top: 1em;
            background-color: #f5f5f5;
        }
    </style>    <title>FIGUEROA_AML_METHYLATION_CLUSTER_5_UP</title></head>

<body>
<nav class="navbar navbar-expand-lg navbar-light bg-light">
    <span class="navbar-brand">
        Molecular Signatures Database
    </span>
</nav>

<div class="container" style="margin-top: 50px; margin-bottom: 50px">
<div class="card">
        <div class="card-header">
            FIGUEROA_AML_METHYLATION_CLUSTER_5_UP
        </div>
        <div class="card-body">
                <p>We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which reflect critical biological differences. We therefore examined the methylation profiles of 344 patients with acute myeloid leukemia (AML). Clustering of these patients by methylation data segregated patients into 16 groups. Five of these groups defined new AML subtypes that shared no other known feature. In addition, DNA methylation profiles segregated patients with CEBPA aberrations from other subtypes of leukemia, defined four epigenetically distinct forms of AML with NPM1 mutations, and showed that established AML1-ETO, CBFb-MYH11, and PML-RARA leukemia entities are associated with specific methylation profiles. We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p &lt; 0.001, adjusted for known covariates).</p>
            <dl>
                <dt>Local Unique Identifier</dt>
                <dd><a href="https://bioregistry.io/msigdb:M2172">M2172</a>
                </dd>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            in taxon (<code>RO:0002162</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/NCBITaxon:9606">NCBITaxon:9606</a></li>
                        </ol>
                    </dt>
                    <dt>
                        <span class="badge badge-primary">Relation</span>
                            has part (<code>BFO:0000051</code>)
                    </dt>
                    <dt>
                        <ol>
                                <li><a href="https://bioregistry.io/ncbigene:124583">ncbigene:124583</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:56941">ncbigene:56941</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:57211">ncbigene:57211</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:5366">ncbigene:5366</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8106">ncbigene:8106</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:2957">ncbigene:2957</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:63934">ncbigene:63934</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:220359">ncbigene:220359</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:1393">ncbigene:1393</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:9063">ncbigene:9063</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:8828">ncbigene:8828</a></li>
                                <li><a href="https://bioregistry.io/ncbigene:3887">ncbigene:3887</a></li>
                        </ol>
                    </dt>
            </dl>
            <span class="badge badge-warning">Term generation via PyOBO is currently under construction</span>
            <blockquote>
                Term(reference=Reference(prefix=&#39;msigdb&#39;, identifier=&#39;M2172&#39;, name=&#39;FIGUEROA_AML_METHYLATION_CLUSTER_5_UP&#39;), definition=&#39;We hypothesized that DNA methylation distributes into specific patterns in cancer cells, which reflect critical biological differences. We therefore examined the methylation profiles of 344 patients with acute myeloid leukemia (AML). Clustering of these patients by methylation data segregated patients into 16 groups. Five of these groups defined new AML subtypes that shared no other known feature. In addition, DNA methylation profiles segregated patients with CEBPA aberrations from other subtypes of leukemia, defined four epigenetically distinct forms of AML with NPM1 mutations, and showed that established AML1-ETO, CBFb-MYH11, and PML-RARA leukemia entities are associated with specific methylation profiles. We report a 15 gene methylation classifier predictive of overall survival in an independent patient cohort (p &lt; 0.001, adjusted for known covariates).&#39;, provenance=[Reference(prefix=&#39;pubmed&#39;, identifier=&#39;20060365&#39;, name=None)], relationships=defaultdict(&lt;class &#39;list&#39;&gt;, {TypeDef(reference=Reference(prefix=&#39;RO&#39;, identifier=&#39;0002162&#39;, name=&#39;in taxon&#39;), comment=None, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=None, holds_over_chain=None): [Reference(prefix=&#39;NCBITaxon&#39;, identifier=&#39;9606&#39;, name=&#39;Homo sapiens&#39;)], TypeDef(reference=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000051&#39;, name=&#39;has part&#39;), comment=&#39;Inverse of part_of&#39;, namespace=None, definition=None, is_transitive=None, is_symmetric=None, domain=None, range=None, parents=[], xrefs=[], inverse=Reference(prefix=&#39;BFO&#39;, identifier=&#39;0000050&#39;, name=&#39;part of&#39;), holds_over_chain=None): [Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;124583&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;56941&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;57211&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;5366&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8106&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;2957&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;63934&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;220359&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;1393&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;9063&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;8828&#39;, name=None), Reference(prefix=&#39;ncbigene&#39;, identifier=&#39;3887&#39;, name=None)]}), properties=defaultdict(&lt;class &#39;list&#39;&gt;, {&#39;category_code&#39;: [&#39;C2&#39;], &#39;sub_category_code&#39;: [&#39;CGP&#39;], &#39;contributor&#39;: [&#39;Arthur Liberzon&#39;], &#39;exact_source&#39;: [&#39;Table 3ES: Hypermethylated&#39;]}), parents=[], synonyms=[], xrefs=[], alt_ids=[], namespace=None, is_obsolete=False)
            </blockquote>
        </div>
    </div></div>

<footer class="footer">
    <p class="small text-center text-muted">
        Generated with PyOBO
    </p>
</footer>

<script src="https://code.jquery.com/jquery-3.2.1.slim.min.js"
        integrity="sha384-KJ3o2DKtIkvYIK3UENzmM7KCkRr/rE9/Qpg6aAZGJwFDMVNA/GpGFF93hXpG5KkN"
        crossorigin="anonymous"></script>
<script src="https://maxcdn.bootstrapcdn.com/bootstrap/4.0.0/js/bootstrap.min.js"
        integrity="sha384-JZR6Spejh4U02d8jOt6vLEHfe/JQGiRRSQQxSfFWpi1MquVdAyjUar5+76PVCmYl"
        crossorigin="anonymous"></script></body>
</html>